CSWYY (China Shineway Pharmaceutical Group) GF Score: 92/100 (As of Jun. 26, 2026) — 15% Above Median


CSWYY China Shineway Pharmaceutical Group Ltd CSWYY
92 GF Score
Price $19.25
GF Value $16.85
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group GF Score?

China Shineway Pharmaceutical Group CSWYY 92 GF Score is 92 as of Jun. 26, 2026, which is 15% above its 10-year median of 80.00. GuruFocus rates CSWYY with a GF Score™ of 92/100 and a GF Value™ of $16.85. The stock has 2 warning signs investors should review.

China Shineway Pharmaceutical Group has the GF Score of 92, which implies that the company might have Highest outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 9/10
2. Profitability Rank : 9/10
3. Growth Rank : 9/10
4. GF Value Rank : 5/10
5. Momentum Rank : 8/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes China Shineway Pharmaceutical Group might have Highest outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


China Shineway Pharmaceutical Group  (OTCPK:CSWYY) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.


China Shineway Pharmaceutical Group GF Score Related Terms


CSWYY vs ZTS: GF Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Shineway Pharmaceutical Group GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's GF Score distribution charts can be found below:

* The bar in red indicates where China Shineway Pharmaceutical Group's GF Score falls into.


CSWYY
92GF Score
China Shineway Pharmaceutical Group Ltd CSWYY
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 92 mean?
China Shineway Pharmaceutical Group (CSWYY) has a GF Score of 92 as of Jun. 26, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 15% above median its historical median of 80.00. Over the past decade, China Shineway Pharmaceutical Group's GF Score has ranged from 35.00 to 96.00.
Is China Shineway Pharmaceutical Group's GF Score too high?
China Shineway Pharmaceutical Group's current GF Score of 92 is 15% above median its 10-year median of 80.00. Over the past 10 years, this metric has ranged from a low of 35.00 to a high of 96.00. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's GF Score compare to ZTS?
China Shineway Pharmaceutical Group's GF Score of 92 can be compared against companies in the Drug Manufacturers industry. Historically, China Shineway Pharmaceutical Group's own GF Score has ranged from 35.00 to 96.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on China Shineway Pharmaceutical Group and its competitors. China Shineway Pharmaceutical Group's current GF Score is 92, which is 15% above median its own 10-year median of 80.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current GF Score of 92. The stock's GF Value™ is $16.85, compared to a current price of $19.25 — trading 14.2% above its estimated fair value. The current GF Score is 92, which is 15% above median its 10-year median of 80.00. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current GF Score is 92 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of $19.25 is trading 14.2% above its estimated GF Value™ of $16.85.

Key valuation signals for CSWYY:

  • GF Score: 92 (15% above median its 10-year median of 80.00)
  • GF Value™: $16.85 vs. price of $19.25 (14.2% above fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score

Get the complete analysis for CSWYY

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.25
Price
$16.85
GF Value